Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment‐r...

Cannabidiol (CBD) Expanded Access Program (EAP), initiated in 2014, provided CBD (Epidiolex®) to patients with treatment-resistant epilepsy (TRE). In the final pooled analysis of 892 patients...